Nano-X Imaging (NNOX) Capital Leases (2021 - 2026)

Nano-X Imaging's (NNOX) quarterly Capital Leases came in at $131000.0 in Q1 2026, down 24.28% on a QoQ basis from $173000.0 in Q4 2025.

Nano-X Imaging (NNOX) Capital Leases (2021 - 2026) Analysis & Trends

Nano-X Imaging (NNOX) has 6 years of Capital Leases data on file, last reported at $131000.0 in Q1 2026.

Quarterly Capital Leases changed N/A year-over-year to $131000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131000.0 (changed N/A YoY) and the FY2025 annual result came in at $173000.0, up 861.11% from the prior year.
Capital Leases declined to $131000.0 in Q1 2026, from $173000.0 in the prior quarter.
In the past five years, Capital Leases ranged from a high of $7.0 billion in Q1 2022 to a low of -$4.7 million in Q1 2023.
A 5-year average of $1.6 billion and a median of $131000.0 in 2026 frame the typical range for Capital Leases.
Annual changes were most pronounced in 2023 — Capital Leases sank 209.76% — and 2025, when it jumped 861.11%.
Tracing NNOX's Capital Leases over 5 years: stood at $4.1 million in 2022, then slumped by 209.76% to -$4.5 million in 2023, then surged by 100.4% to $18000.0 in 2024, then jumped by 861.11% to $173000.0 in 2025, then fell by 24.28% to $131000.0 in 2026.
The last three Capital Leases figures came in at $131000.0 (Q1 2026), $173000.0 (Q4 2025), and $18000.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn
10	Nano-X Imaging	61,821.67	-44.16 Mn	-2.59 Mn

Download Data